AstraZeneca CEO Considers Shifting Stock Listing to US
Pascal Soriot, the chief executive of AstraZeneca, has reportedly expressed interest in moving the company’s stock market listing from the UK to the US.
The head of Britain’s most valuable listed firm has privately discussed favoring a shift to New York, according to the Times, which also noted that he had weighed relocating the company’s legal headquarters.
AstraZeneca’s shares rose 2.8% on Tuesday, with much of the gain occurring after the report was published.
Such a move would be a significant setback for the London Stock Exchange, which has already seen several major companies leave in pursuit of higher valuations. Recent departures from the FTSE 100 include equipment rental firm Ashtead, betting company Flutter Entertainment, construction supplier CRH, and packaging business Smurfit Westrock.
While the UK government would likely oppose AstraZeneca’s relocation, it lacks the authority to prevent it. Labour recently identified life sciences as a priority sector in its industrial strategy.
AstraZeneca declined to comment.
The company is believed to have privately voiced dissatisfaction after the NHS refused to fund its breast cancer drug, Enhertu, due to cost concerns. Earlier this year, the Cambridge-based firm withdrew from a £450m vaccine project in Liverpool, citing insufficient government financial backing.
Since Soriot became CEO in 2012, AstraZeneca’s market value has more than tripled. It now exceeds that of Shell – also rumored to be considering a US move – and HSBC, reaching £157bn.
The US remains the largest pharmaceutical market globally, with the highest per-capita drug spending, despite shorter life expectancies than some nations. UK executives often argue their firms are undervalued compared to US peers.
Soriot has highlighted ambitions to expand in the US. Last November, he told investors the company aims for further growth there as part of its 2030 strategy, according to data firm Alphasense. He described the US as a critical market that fosters innovation, vowing continued investment to accelerate expansion.
Read next
Four-day work week trial in Scotland boosts productivity and worker wellbeing
Trial of Four-Day Workweek Shows Positive Results in Scotland
Higher productivity and better employee well-being were observed in a year-long test of a four-day workweek conducted by the Scottish government.
Two public organizations, South of Scotland Enterprise (SOSE) and Accountant in Bankruptcy (AiB), participated in the trial, which began in
"Poll: Americans Pin Rising Living Costs on Trump"
Americans are facing financial difficulties, dealing with debt and higher living expenses, and many hold the Trump administration and corporate interests responsible for worsening economic conditions for working families, a recent survey shows.
Six in 10 respondents blame the Trump administration for increasing their cost of living, according to a
"UK Supreme Court to rule on car finance secret commission case"
UK Supreme Court to Rule on £44bn Car Finance Dispute
The UK’s highest court is set to issue its decision on the £44bn car finance dispute, which could determine whether millions of drivers are eligible for compensation due to unfair lending practices.
The Supreme Court’s ruling, expected after